Evidence map›Paper›PMID 32375836›Full record

ReviewCritical care (London, England)2020

Revisited: Therapeutic and toxic blood concentrations of more than 1100 drugs and other xenobiotics.

Martin Schulz, Achim Schmoldt, Hilke Andresen-Streichert, Stefanie Iwersen-Bergmann

Open access · goldAbstract readReview
In one paragraph

Review in Critical care (London, England), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 121 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
121citing papers in PubMed, 2 pooled it
35.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

121 citing papers in PubMed, 2 syntheses or guidelines pooled it, 334 citations in OpenAlex.

  1. A Reappraisal of the Effects of L-type CaFunction (Oxford, England) · 2023
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. A Mechanistic Clinical Trial Using (Circulation. Arrhythmia and electrophysiology · 2022
    Trial
  6. Article
  7. Article
  8. Suicide by flecainide: a case report and review of the literature.Forensic science, medicine, and pathology · 2026
    Review
  9. Article
  10. Article
  11. Article
  12. mBio · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Elevated Serum Concentrations of Lacosamide and Perampanel in a Pediatric Patient Following Coadministration of Clarithromycin forThe journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG · 2026
    Article
  20. Article

61 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Martin SchulzDrug Commission of German Pharmacists (AMK), Heidestraße 7, 10557, Berlin, Germany. m.schulz@fu-berlin.de.ORCID 0000-0002-5876-7322
Achim SchmoldtInstitute of Legal Medicine, University Medical Centre Hamburg-Eppendorf, Butenfeld 34, 22529, Hamburg, Germany.
Hilke Andresen-StreichertDepartment of Forensic Toxicology, Institute of Legal Medicine, Faculty of Medicine, University of Cologne, Melatengürtel 60-62, 50823, Cologne, Germany.
Stefanie Iwersen-BergmannInstitute of Legal Medicine, University Medical Centre Hamburg-Eppendorf, Butenfeld 34, 22529, Hamburg, Germany.
Universität Hamburg · DEFederal Union of German Associations of Pharmacists · DEUniversity of Cologne · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In order to assess the significance of drug/substance levels measured in intensive care medicine and clinical and forensic toxicology as well as for therapeutic drug monitoring, it is essential that a comprehensive collection of data is readily available. We revisited and expanded our 2012 compilation of therapeutic and toxic plasma concentration ranges as well as half-lives of now more than 1100 drugs and other xenobiotics.Data have been abstracted from original papers, text books, and previous compilations and have been completed with data collected in our own forensic and clinical toxicology laboratories. We compiled the data presented in the table and the corresponding annotations over the past 30+ years. A previous compilation was completely double-checked, revised, and updated, if necessary. In addition, more than 200 substances, especially drugs who have been introduced since 2012 to the market as well as illegal drugs and other xenobiotics which became known to cause intoxications were added. We carefully referenced all data. Moreover, the annotations providing details were updated and revised, when necessary.For more than 1100 drugs and other xenobiotics, therapeutic ("normal") and, if data was available, toxic, and comatose-fatal plasma/blood concentrations as well as elimination half-lives were compiled in a table.In case of intoxications, the blood concentration of the substance and/or metabolite better predicts the clinical severity of the case when compared to the assumed amount and time of ingestion. Comparing and contrasting the clinical case against the data provided, including the half-life, may support the decision for or against further intensive care. In addition, the data provided are useful for the therapeutic monitoring of pharmacotherapies, to facilitate the diagnostic assessment and monitoring of acute and chronic intoxications as well as to support forensic and clinical expert opinions.

Indexed as

Drug Dosage CalculationsDrug MonitoringHumansSeverity of Illness IndexXenobioticsXenobioticsCritical careDrug monitoringDrug-related side effects and adverse reactionsHumansIntoxicationOverdoseXenobiotics/bloodXenobiotics/toxicity

Identifiers

PMID32375836
PMCPMC7201985
OpenAlexW3022984442

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.